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Discussion
Dr W. Randolf Chitwood (Greenville, NC). In this study, you
prospectively randomized 44 patients undergoing mitral surgery
who had concomitant TR with a dilated annulus to receive or
not receive a concomitant band annuloplasty. By preoperative
echocardiography, each cohort had less than 2+ TR but a dilated
annulus to more than 40 mm by echocardiography. At 12 months
after surgery, the annuloplasty cohort had no TR and only 19% in
the control group had no TR. The absence of TR was reflected in,
as you said, reversed remodeling and improvement in patient func-
tionality. On the basis of your data, you are suggesting that we per-
form prophylactic ringing of the TV.
Many share your view that correction of mitral insufficiency
does not correct functional TR automatically. Treatment of this mi-
tral lesion alone decreases the afterload but does not correctThe Journal of Thoracic and Catricuspid annular dilatation, preload, or RV function. The TV
may have significant pathologic changes even when associated
with mild regurgitation. We know that. Moreover, differential
loading conditions often make the preoperative echocardiographic
assessment inaccurate.
The seminal article by Dreyfus and colleagues5 in 2005 recom-
mended that the decision to perform a tricuspid annuloplasty
should be based on annular diameter rather than the level of regur-
gitation, and they considered that an annular diameter of more than
70 mm (now, this was measured directly in the operating room, not
on echocardiography, and that was more than twice the diameter of
the normal valve) was an indication for a concomitant ring or re-
pair. Your study has shown that RV reverse remodeling is good
and functionality is great. What was the size of the valve annulus
when you were in the operating room? Professor Mohr subscribes
to the same thing in Leipzig if it is more than 65 mm.
In contrast, at the Mitral Valve Conclave in New York City, Ra-
kesh Suri from the Mayo Clinic reported a large series of patients
with different levels of tricuspid insufficiency. They showed that
grades 1 and 2 regurgitation progressed only slightly over time
and that atrial fibrillation was a risk factor. So lower levels of
TR did not affect long-term survival, and they did not put a ring
in. That is in contradistinction to what you are saying.
Many surgeons still do not agree with a ‘‘prophylactic tricuspid
annuloplasty.’’ Moreover, there is even disagreement between our
guidelines in Europe and the United States. In Europe, a class IIa
indication exists formoderate TRwith a dilated annulus in a patient
undergoing a mitral valve operation, but in the United States, our
guidelines state that a tricuspid annuloplasty ‘‘may be considered’’
a class IIb indication in the presence of annular dilatation and pul-
monary hypertension. Therefore, there is a significant conundrum
between surgeons and cardiologists on what to do.
I have 3 questions for you. Considering that the tricuspid
annular size can vary with loading conditions and that echocardi-
ography measurements can be inaccurate, do you measure the an-
nulus intraoperatively? I think you said you just use the anterior
leaflet to size the ring or band you were using. Do you put any cre-
dence in the intraoperative measurement?
Dr Benedetto. We decided to measure the tricuspid annulus
with preoperative echocardiography because we think that intrao-
perative measurement is not reliable or easily reproducible. We
found an agreement between the judgment of tricuspid dilatation
assessed by preoperative echocardiography and intraoperative
examination.
Dr Chitwood. Did you perform transesophageal echocardiog-
raphy in the operating room or is this all transthoracic?
Dr Benedetto. In the operating room we did not perform trans-
esophageal echocardiography to measure the annulus but only to
assess the result of TV repair.
Dr Chitwood. The second question is, Jim Gammie recently
suggested—and this will be published in the Annals of Thoracic
Surgery, it is in press—using an undersized ring to repair the
TV. They used no ring larger than 28 mm. What is your optimal
size and does it matter as long as it is a smaller annulus? What
do you think the optimal size is?
Dr Benedetto. The median ring size in our series was 32 mm.
We select the ring size on the basis of the septal leaflet attachment,
and we did not undersize this measure.rdiovascular Surgery c Volume 143, Number 3 637
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DDr Chitwood. Many patients who do have moderate to severe
tricuspid insufficiency, and have a repair and the ventricle changes,
develop recurrent tricuspid disease. What do you do when you
have that dilated ventricle, pulmonary hypertension, and more
than moderate regurgitation? Do you just put a ring in or do you
augment? What do you do?
Dr Benedetto.We are aware that functional tricuspid pathology
is similar to functional mitral regurgitation and that the result of
tricuspid repair is strongly related to the preoperative RV condi-
tions. In patients with a highly remodeled right ventricle, the
risk of a failure is high. However, we do not adopt an alternative
surgical strategy in these cases.
Dr Patrick McCarthy (Chicago, Ill). By way of disclosure, I
am the inventor of the MC3 ring (Edwards Lifesciences, Irvine,
Calif). I was interested in the atrial fibrillation at 1 year. Do you
have any data on how common that was? Was that, for instance,
more common in the control group and did it correlate with the
6-minute walk test? Excellent article, and it was good to see a pro-
spective randomized surgical trial.
Dr Benedetto. For the small sample size, subgroup analysis was
not possible, but we have the data for atrial fibrillation. Nine pa-
tients in the annuloplasty group had a history of atrial fibrillation,
and 6 of them underwent aMaze procedure. Because 3 of them had
a left atrium greater than 60 mm, we decided not to perform this
procedure in these patients. Therefore, at 1-year follow-up, 5 pa-
tients treated had sinus rhythm and only 1 patient had atrial fibril-
lation. In our annuloplasty group, of 12 patients with a preoperative638 The Journal of Thoracic and Cardiovascular Surghistory of atrial fibrillation, 9 were treated because the others had
a left atrium greater than 60 mm. Only 1 patient had recurrence of
atrial fibrillation. Overall, we had persistent sinus rhythm in ap-
proximately 80% of patients treated for atrial fibrillation.
Dr Norberto De Vega (Malaga, Spain). I rise to congratulate
Dr Benedetto and colleagues for the elegant presentation. Forty
years ago, a Canadian surgeon, Pierre Groudin, published a semi-
nal article in the Journal, ‘‘The Tricuspid Valve: A Surgical Chal-
lenge.’’ Since then, that was 40 years, for too many years we
surgeons have been trying to find the best technique to address
the problem instead of trying to find the best indication. Unfortu-
nately, many times we have followed the indications of the cardi-
ologists, who have been wrong. Nowadays, I believe that in most
mitral surgical cases, the tricuspid annulus should be fixed or re-
duced. It can be done without any added risk and can prolong
the well-being of many patients for many years.
Have you ever tried any other technique apart from the ring? I
know that my Indian and Chinese friends who probably are here
would agree that $2000 for this prophylactic surgery may be too
much for many patients.
Dr Benedetto. We decided to perform tricuspid annuloplasty
with a ring because recent evidence suggests that ring annuloplasty
is associated with better results than suture annuloplasty. However,
the policy in our department is to routinely performDeVega suture
annuloplasty. In the present study, we used ring annuloplasty to
avoid any criticism, but outside of the present study, we have op-
timal results with the De Vega technique.ery c March 2012
